Oxaliplatin Injection bulk supplier for pharma manufacturers

Oxaliplatin Injection Suppliers & Bulk Manufacturers

Available Forms: Solution for Injection

Available Strengths: 50 mg/10 mL, 100 mg/20 mL, 200 mg/40 mL

Reference Brands: Eloxatin(US & EU)

Oxaliplatin Injection (50 mg, 100 mg, 200 mg) is a platinum-based chemotherapy drug used in the treatment of colorectal cancer. Administered via IV infusion, it is a key component of the FOLFOX regimen and widely used in both the U.S. and EU. Oxaliplatin disrupts DNA replication in cancer cells, making it essential in modern oncology treatment protocols.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Oxaliplatin Injection is a platinum-based chemotherapeutic agent available in 50 mg, 100 mg, and 200 mg strengths for IV infusion. Widely used in the U.S. and EU, it is a key component of the FOLFOX regimen for the treatment of advanced and metastatic colorectal cancer. Oxaliplatin interferes with DNA replication, leading to cancer cell death. Approved for both adjuvant and palliative therapy, it plays a vital role in oncology B2B distribution. Available as a solution for infusion, Oxaliplatin supports effective cancer management and enhances treatment outcomes for colorectal cancer patients across global markets

Oxaliplatin Injection — third party manufacturing & bulk supply

Oxaliplatin Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Oxaliplatin Injection is supplied as Solution for Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Oxaliplatin Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Oxaliplatin Injection →

Back to Listing

Frequently Asked Questions

Oxaliplatin injection is used as a chemotherapy medication to treat various cancers, including colorectal cancer, gastric cancer, and pancreatic cancer. It is often used in combination with other anticancer drugs to enhance efficacy.

Oxaliplatin injection is made from the active pharmaceutical ingredient oxaliplatin, a platinum-based antineoplastic agent that interferes with DNA replication in cancer cells, leading to cell death.

Oxaliplatin injection is marketed under the brand name Eloxatin, as well as several generic versions depending on the region and manufacturer.

Oxaliplatin injection is manufactured by multiple companies worldwide, including Sanofi (Eloxatin), Sandoz, Teva, Fresenius Kabi, Accord Healthcare, Hospira, Medac, and other licensed generic manufacturers.

The complete generic name is oxaliplatin.

Common brand names include Eloxatin and other region-specific generics.

Oxaliplatin injection is manufactured in FDA-, EMA-, MHRA-, and SFDA-approved facilities across the USA, EU, UK, and Saudi Arabia, depending on the brand and manufacturer.